Quality of life in patients with psoriasis vulgaris uality of life in patients with psoriasis vulgaris during the COVID-19 pandemic

Vasileva, Mirela and Boskovski Briskoska, Vesna and Majhosheva, Mila and Vasileva, Stojka and Vasilev, Simon and Drakalska, Elena (2020) Quality of life in patients with psoriasis vulgaris uality of life in patients with psoriasis vulgaris during the COVID-19 pandemic. Our Dermatology Online Journal. ISSN 2081-9390

Preview	Text 1.COVID-19-Article.pdf Download (223kB) | Preview
	Text index.html Download (53kB)

Abstract

Background: Psoriasis is a chronic inflammatory dermatological disease that has a major impact on quality of life.
Skin diseases are the most common somatic causes of psychological disorders and, conversely, under the influence
of a psychological disorder, there is usually a cutaneous manifestation. This is the main reason for conducting this
research during the COVID-19 pandemic, a time when most of the population is under constant stress. The research
is aimed at determining the quality of life of patients with psoriasis. Materials and Methods: In this research,
we employed two questionnaires. One collected particulars such as the patient’s age and gender. The other was a
DLQI (Dermatological Life Quality Index) questionnaire. Due to the epidemiological situation, the questionnaire
was completed by patients who came for a control examination, and most of them were contacted by phone; some
completed the questionnaires online. One hundred six respondents participated actively in this research. Results: The
lowest score of the Dermatological Life Quality Index (DLQI) is 3, and the highest is 29. The most commonly received
scores were 4 and 8, among which the score of 4 was given to 19 (17.9%) respondents and the score of 8 was given to
21 (19.8%) respondents. 69.8% of the respondents experienced problems with the affected parts of the skin rated as
answers “moderately” or “a lot.” In terms of health issues, female respondents had lower values than male respondents.
However, by applying the t-test to determine the statistical significance of the difference with p ≤ 0.05, the value of t
was determined to be -0.48 (p = 0.31), which means that there was no statistically significant difference.
Conclusion: When compared to the results of studies performed several years ago, together with this study performed
during the COVID-19 pandemic, there are no major differences in terms of quality of life in patients with psoriasis.

Item Type:	Article
Subjects:	Medical and Health Sciences > Other medical sciences
Divisions:	Faculty of Medical Science
Depositing User:	Elena Drakalska
Date Deposited:	06 Oct 2020 08:44
Last Modified:	06 Oct 2020 08:44
URI:	https://eprints.ugd.edu.mk/id/eprint/26576

Actions (login required)

View Item